21.30
Draftkings Inc stock is traded at $21.30, with a volume of 11.75M.
It is down -0.07% in the last 24 hours and down -18.23% over the past month.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number-two or -three revenue share position across states where it competes. With its predictive market launch in 2025, DraftKings is now live with online or retail sports betting in most all states and i-gaming in five states, with both products available to around 40% of Canada's population. In 2025, sports revenue was 63% of total sales, i-gaming 30%, and fantasy and lottery 7%.
See More
Previous Close:
$21.25
Open:
$21.06
24h Volume:
11.75M
Relative Volume:
1.00
Market Cap:
$10.58B
Revenue:
$6.29B
Net Income/Loss:
$58.64M
P/E Ratio:
353.90
EPS:
0.0602
Net Cash Flow:
$569.28M
1W Performance:
-5.50%
1M Performance:
-18.23%
6M Performance:
-8.90%
1Y Performance:
-50.56%
Draftkings Inc Stock (DKNG) Company Profile
Name
Draftkings Inc
Sector
Industry
Phone
(617) 986-6744
Address
222 BERKELEY STREET, BOSTON, MA
Compare DKNG vs FLUT, SGHC, CHDN, RSI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DKNG
Draftkings Inc
|
21.31 | 10.55B | 6.29B | 58.64M | 569.28M | 0.0602 |
|
FLUT
Flutter Entertainment Plc
|
81.50 | 14.91B | 17.02B | -533.00M | 484.75M | -2.1477 |
|
SGHC
Super Group Sghc Limited
|
11.97 | 6.11B | 2.33B | 246.00M | 0 | 0.4846 |
|
CHDN
Churchill Downs Inc
|
79.08 | 5.61B | 2.95B | 391.30M | 564.50M | 5.3938 |
|
RSI
Rush Street Interactive Inc
|
19.61 | 2.38B | 1.24B | 89.03M | 118.76M | 0.3198 |
Draftkings Inc Stock (DKNG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-24-26 | Downgrade | MoffettNathanson | Buy → Neutral |
| Mar-17-26 | Downgrade | Argus | Buy → Hold |
| Feb-17-26 | Reiterated | Needham | Buy |
| Feb-06-26 | Reiterated | Bernstein | Outperform |
| Jan-16-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-15-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-21-25 | Initiated | Citigroup | Buy |
| Nov-18-25 | Initiated | Wells Fargo | Equal Weight |
| Nov-10-25 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Nov-04-25 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-09-25 | Upgrade | Berenberg | Hold → Buy |
| Oct-07-25 | Reiterated | Mizuho | Outperform |
| Oct-06-25 | Reiterated | Jefferies | Buy |
| Oct-01-25 | Downgrade | Northland Capital | Outperform → Under Perform |
| Jul-01-25 | Reiterated | Citigroup | Buy |
| Jun-23-25 | Initiated | JP Morgan | Overweight |
| Jun-04-25 | Initiated | Bernstein | Outperform |
| Apr-22-25 | Reiterated | BTIG Research | Buy |
| Jan-08-25 | Reiterated | Susquehanna | Positive |
| Oct-18-24 | Reiterated | Mizuho | Outperform |
| Oct-07-24 | Reiterated | Susquehanna | Positive |
| Sep-10-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Sep-04-24 | Reiterated | Susquehanna | Positive |
| Sep-04-24 | Reiterated | UBS | Buy |
| Jul-01-24 | Reiterated | Oppenheimer | Outperform |
| May-06-24 | Reiterated | Needham | Buy |
| Apr-16-24 | Initiated | Goldman | Buy |
| Mar-27-24 | Reiterated | Needham | Buy |
| Mar-26-24 | Initiated | Mizuho | Buy |
| Mar-25-24 | Reiterated | Susquehanna | Positive |
| Feb-28-24 | Reiterated | Morgan Stanley | Overweight |
| Feb-23-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Reiterated | Oppenheimer | Outperform |
| Feb-13-24 | Reiterated | Oppenheimer | Outperform |
| Feb-13-24 | Reiterated | Piper Sandler | Overweight |
| Jan-19-24 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| Jan-19-24 | Upgrade | Stifel | Hold → Buy |
| Jan-09-24 | Initiated | BMO Capital Markets | Outperform |
| Nov-27-23 | Reiterated | Argus | Buy |
| Oct-24-23 | Upgrade | MoffettNathanson | Hold → Buy |
| Sep-26-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-09-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-08-23 | Upgrade | Truist | Hold → Buy |
| Aug-07-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-18-23 | Reiterated | ROTH MKM | Sell |
| Jul-17-23 | Reiterated | Jefferies | Buy |
| Jul-14-23 | Reiterated | Morgan Stanley | Overweight |
| Jul-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-12-23 | Reiterated | The Benchmark Company | Buy |
| May-22-23 | Upgrade | UBS | Neutral → Buy |
| May-08-23 | Reiterated | ROTH MKM | Sell |
| May-05-23 | Reiterated | BTIG Research | Buy |
| May-05-23 | Reiterated | BofA Securities | Neutral |
| May-05-23 | Reiterated | Oppenheimer | Outperform |
| May-05-23 | Reiterated | The Benchmark Company | Buy |
| Apr-13-23 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Mar-07-23 | Upgrade | Argus | Hold → Buy |
| Feb-17-23 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-09-23 | Downgrade | ROTH Capital | Neutral → Sell |
| Feb-09-23 | Downgrade | ROTH MKM | Neutral → Sell |
| Jan-24-23 | Initiated | Stifel | Hold |
| Dec-12-22 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-28-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-18-22 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Redburn | Neutral |
| Oct-06-22 | Initiated | Exane BNP Paribas | Underperform |
| Aug-17-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-29-22 | Initiated | Barclays | Equal Weight |
| Jun-28-22 | Initiated | JMP Securities | Mkt Outperform |
| Jun-23-22 | Resumed | Morgan Stanley | Overweight |
| May-16-22 | Resumed | Jefferies | Buy |
| Mar-07-22 | Downgrade | Argus | Buy → Hold |
| Feb-22-22 | Reiterated | BofA Securities | Neutral |
| Feb-22-22 | Reiterated | Canaccord Genuity | Buy |
| Feb-22-22 | Reiterated | Deutsche Bank | Hold |
| Feb-22-22 | Reiterated | Needham | Buy |
| Feb-22-22 | Reiterated | Oppenheimer | Outperform |
| Feb-22-22 | Upgrade | ROTH Capital | Sell → Neutral |
| Feb-22-22 | Reiterated | Truist | Hold |
| Feb-22-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-26-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-13-21 | Initiated | MoffettNathanson | Neutral |
| Nov-08-21 | Reiterated | Deutsche Bank | Hold |
| Nov-08-21 | Reiterated | Oppenheimer | Outperform |
| Nov-08-21 | Reiterated | ROTH Capital | Sell |
| Nov-08-21 | Reiterated | Truist | Hold |
| Nov-02-21 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-27-21 | Initiated | BTIG Research | Neutral |
| Oct-12-21 | Initiated | ROTH Capital | Sell |
| Oct-11-21 | Initiated | Citigroup | Buy |
| Sep-15-21 | Initiated | Wells Fargo | Overweight |
| Sep-14-21 | Reiterated | Craig Hallum | Buy |
| Aug-09-21 | Reiterated | The Benchmark Company | Buy |
| May-12-21 | Upgrade | Berenberg | Sell → Hold |
| May-03-21 | Upgrade | Cowen | Market Perform → Outperform |
| Apr-30-21 | Initiated | Guggenheim | Buy |
| Apr-27-21 | Initiated | Needham | Buy |
| Mar-23-21 | Reiterated | Goldman | Buy |
| Mar-10-21 | Reiterated | The Benchmark Company | Buy |
| Feb-01-21 | Reiterated | The Benchmark Company | Buy |
| Jan-27-21 | Initiated | Bernstein | Outperform |
| Jan-26-21 | Upgrade | Goldman | Neutral → Buy |
| Jan-20-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-19-21 | Initiated | Berenberg | Sell |
| Dec-07-20 | Initiated | JP Morgan | Neutral |
| Nov-24-20 | Initiated | UBS | Neutral |
| Nov-20-20 | Initiated | Piper Sandler | Overweight |
| Oct-12-20 | Initiated | Credit Suisse | Outperform |
| Oct-12-20 | Initiated | Deutsche Bank | Hold |
| Oct-08-20 | Initiated | Cowen | Market Perform |
| Oct-01-20 | Initiated | Needham | Buy |
| Sep-25-20 | Initiated | Argus | Buy |
| Sep-24-20 | Initiated | Macquarie | Outperform |
| Sep-15-20 | Reiterated | The Benchmark Company | Buy |
| Sep-14-20 | Initiated | Wolfe Research | Peer Perform |
| Sep-09-20 | Initiated | Evercore ISI | Outperform |
| Sep-08-20 | Initiated | BofA Securities | Neutral |
| Sep-02-20 | Initiated | Truist | Hold |
| Aug-28-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-17-20 | Reiterated | The Benchmark Company | Buy |
| Jul-31-20 | Initiated | The Benchmark Company | Buy |
| Jul-01-20 | Initiated | Stephens | Overweight |
| Jun-26-20 | Initiated | Rosenblatt | Buy |
| Jun-22-20 | Initiated | Jefferies | Buy |
View All
Draftkings Inc Stock (DKNG) Latest News
Is Football Season Powering DraftKings (NASDAQ:DKNG) Higher This Week? - Kalkine Media
DraftKings shows strong fundamentals and 54% st... - pluang.com
StoneX reiterates DraftKings stock Buy rating on Predictions investment By Investing.com - Investing.com
DraftKings: The Market Focuses Too Much On Concerns (NASDAQ:DKNG) - Seeking Alpha
StoneX Reiterates Buy Rating on DraftKings Inc. (DKNG) - StreetInsider
DraftKings Falls 7.6%: Is Kalshi's NFL Lead Really That Big? - MarketBeat
DraftKings Inc. (DKNG) stock price, news, quote and history - Yahoo Finance UK
Citizens cuts DraftKings stock price target on prediction market investment By Investing.com - Investing.com UK
DraftKings: Prediction Pessimism Overly DoneH2'26 Outperformance May Deliver Breakout - Seeking Alpha
DraftKings (DKNG) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Is DraftKings betting big on losing gamblers? -- update (DKNG:NASDAQ) - Seeking Alpha
DraftKings Stock Nears 52-Week Low: What's Going On? - Benzinga
DraftKings Drops 4% as Prediction-Market Spending Plans Stir Margin Doubts; Flutter Entertainment Slips, Robinhood Ticks Up - AOL.com
DraftKings Inc. (DKNG) Stock Price, News, Quote & History - Yahoo! Finance Canada
DraftKings Beats Class Action Over Voided NBA Game Bets - Law360
Lottery Numbers: How Much was Won on Powerball® in MA – 9/21/26 - DraftKings Network
DraftKings online casino Maine: What is known so far? - SportsLine
DraftKings Sees Strong NFL Start, Prediction Markets Surge as $1B EBITDA Target Holds - TradingView
DraftKings (NASDAQ:DKNG) Trading 6.3% HigherWhat's Next? - MarketBeat
Can DKNG's Vertical Integration Unlock a 30% Adjusted EBITDA Margin? - TradingView
DraftKings used AI to target losing bettors: 'The best investment would be a problem gambler' - New York Post
Tenth Man Spins New Work For DraftKings 08/28/2026 - MediaPost
DraftKings Fights to Revoke Interactive Games Geolocation Patent - Gambling News
Lottery Numbers: Multiple Jackpocket Customers Won Big on Powerball® – 9/19/26 - DraftKings Network
DraftKings may be using AI to target the app's biggest losers - Yahoo Finance
Citizens reiterates DraftKings stock rating on NFL pricing data By Investing.com - Investing.com Australia
Citizens reiterates DraftKings stock rating on NFL pricing data - Investing.com
DraftKings Announces Jason Robins’ Participation in Upcoming Event - Business Wire
Trump’s New Middle East Dilemma, and How DraftKings Uses A.I. to Target Gamblers - The New York Times
Sports betting apps prod and entice fans as gambling exacts a growing financial toll - CBS News
ETFs Investing in DraftKings, Inc. Class A Stocks - TradingView
DraftKings Is Utilizing AI To Identify Gamblers Who Are Most Likely To Lose Bets And Prey On Them - BroBible
DKNG Looks 58.7% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
DraftKings Promo Code: Bet $5, Get $200 in Bonus Bets (September 2026) - Athlon Sports
How DraftKings Uses A.I. to Target the Gamblers Likeliest to Lose - The New York Times
WINTON GROUP Ltd Sells 133,455 Shares of DraftKings Inc. $DKNG - MarketBeat
DraftKings (DKNG) Stock Trades At A Discount To Fair Value - Yahoo Finance
DraftKings' Owner Urges PTAB To Invalidate Lutnick's Patent - Law360
Is DraftKings Inc (DKNG) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
DraftKings Inc. Cl A stock falls Friday, underperforms market - marketwatch.com
What’s Driving DraftKings (NASDAQ:DKNG) Into A New Phase? - Kalkine Media
DraftKings Asks Patent Office to Void Cantor Fitzgerald Patent - Bloomberg Law News
DraftKings, FanDuel Lawsuit Alleges VIP Managers Fueled More Than $130K in Gambling Losses - aboutlawsuits.com
DraftKings (NASDAQ:DKNG) Price Target Lowered to $48.00 at UBS Group - MarketBeat
UBS cuts DraftKings stock price target on revenue normalization - Investing.com
UBS Adjusts DraftKings Price Target to $48 From $49, Maintains Buy Rating - marketscreener.com
DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2 - StreetInsider
DraftKings (NASDAQ:DKNG) Given Buy Rating at Needham & Company LLC - MarketBeat
What's Going On With DraftKings Stock on Friday? - Benzinga
Needham reiterates Buy on DraftKings stock, $35 target - Investing.com
Needham Reiterates Buy Rating on DraftKings Inc. (DKNG) Post Management Meet - StreetInsider
Draftkings Inc Stock (DKNG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):